ATX-091
Asset
Inhibits DRP1, targeting mitochondrial fragmentation.
- Stage
- Preclinical
- Modality
- Small molecule
- Target
- Not known
- 3
- Indications
- 0
- Trials
- 1
- Developer
Indications
3Ischemia/stroke
Preclinical, firstatomtx.com, 10 Oct 2026
Parkinson's disease
Preclinical, firstatomtx.com, 10 Oct 2026
Rare & orphan neuropathies
Preclinical, firstatomtx.com, 10 Oct 2026
In the full profile
- Owner and partners1
- Competitors12
Every asset’s record: target, stage, trials and the evidence behind it.